LRCP Awardees Fall 2019 Catalyst Grants for Translational Cancer Research

Congratulations to Awardees of the 2019 Fall Catalyst Grant Competition

Dr. Alison Allan
Relationship between pEMT status, epigenetic modifications, and migratory mode in prostate cancer
Amount Funded: $25,000 (Translational Prostate Cancer Research focus)
 
Dr. Glenn Bauman, Co-Applicants:  Drs. Aaron Ward, Madeleine Moussa, Rohann Correa
Assessment of novel radio-genomic correlations in multi-focal prostate cancer
Amount Funded: $25,000 (Translational Prostate Cancer Research focus)
 
Dr. Ricardo Fernandes, Co-Applicant: Dr. Saman Maleki 
Preventing immune-related adverse events in renal cell carcinoma patients treated with combination immunotherapy using fecal microbiota transplantation
Amount Funded: $24,195 (Keith Samitt Translational Research Grant)
 
Dr. Ana Lohmann
Concordance between Liquid and Tissue Biopsy in Newly Diagnosed Metastatic Breast Cancer
Amount Funded: $25,000 (Translational Breast Cancer Research focus)
 
Dr. Saman Maleki 
The role of IL12 and IL27 on inducing CD39 expression on tumour-specific CD8+ T-cells
Amount Funded: $23,854 (Keith Samitt Translational Research Grant)
 
Dr. Armen Parsyan, Co-Applicant: Dr. Alison Allan 
Anticancer Effects of Radiation Therapy Combined with PLK4 Inhibitor CFI-400945 in Breast Cancer
Amount Funded: $25,000 (Translational Breast Cancer Research focus)
 
Dr. Silvia Penuela, Co-Applicants: Drs. John Ronald, Matthew Hebb
Pannexin 1 channels in glioblastoma multiforme
Amount Funded: $25,000 (Keith Samitt Translational Research Grant)
 
Dr. Trevor Shepherd, Co-Applicant:  Matthew Borrelli
Characterization of mitochondrial function and mitophagy during bioenergetic stress in ovarian cancer Amount Funded: $21,500  (Translational Ovarian Cancer Research focus)
 
Dr. Eva Turley
RHAMM peptide mimetics in multiple myeloma
Amount Funded: $25,000 (Translational Myeloma Cancer Research focus)
 
Dr. Anargyros Xenocostas , Co-Applicants:  Drs. Alejandro Lazo-Langner, Shun-Cheng Li
Dynamic Epigenomic and Proteomic Profiling in Patients with Myelodysplastic Syndromes: A Pilot Study
Amount Funded $22,500 (Translational Leukemia Cancer Research focus)
 

Congratulations and well done!

Joe Mymryk, PhD, Chair, Grant Review Panel
LRCP Catalyst Grants for Translational Cancer Research and Training

Glenn Bauman, MD, Chair/Chief
Department of Oncology

Gabriel DiMattia, PhD, Interim Director
Cancer Research Laboratory Program